Cargando…
MCM6 Promotes Hepatocellular Carcinoma Progression via the Notch Pathway: Clinical, Functional, and Genomic Insights
OBJECTIVE: To evaluate the expression profile of MCM6 in HCC and the relationship between MCM6 level and clinicopathological parameters through bioinformatics analysis of several databases. METHODS: MCM expression level, clinical parameters, survival data, and gene set enrichment analysis were analy...
Autores principales: | Hou, Liangjuan, Zeng, Xin, Li, Xuan, Zhao, Chune, Zou, Juan, Li, Yukun, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203181/ https://www.ncbi.nlm.nih.gov/pubmed/35720029 http://dx.doi.org/10.1155/2022/3116303 |
Ejemplares similares
-
Retracted: MCM6 Promotes Hepatocellular Carcinoma Progression via the Notch Pathway: Clinical, Functional, and Genomic Insights
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression
por: Liu, Zhikun, et al.
Publicado: (2018) -
MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis()()
por: Issac, Marianne Samir Makboul, et al.
Publicado: (2019) -
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
por: Zhou, Xin, et al.
Publicado: (2022) -
m(6)A‐Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis
por: Yang, Xia, et al.
Publicado: (2023)